Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of Pseudomonas aeruginosa
about
Glycosyltransferases and Transpeptidases/Penicillin-Binding Proteins: Valuable Targets for New AntibacterialsResistance to antibiotics targeted to the bacterial cell wallThe Role of the β5–α11 Loop in the Active-Site Dynamics of Acylated Penicillin-Binding Protein A from Mycobacterium tuberculosisCrystal structures of the transpeptidase domain of the Mycobacterium tuberculosis penicillin-binding protein PonA1 reveal potential mechanisms of antibiotic resistanceTargeting Antibiotic ResistanceEvolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis cloneThe enzymes of β-lactam biosynthesis.Clinically relevant Gram-negative resistance mechanisms have no effect on the efficacy of MC-1, a novel siderophore-conjugated monocarbam.Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing.Exploiting bacterial iron acquisition: siderophore conjugates.Microbial siderophores: a mini review.Siderophore conjugates.New antibacterial agents: patent applications published in 2010.Crystal structures of penicillin-binding protein 3 in complexes with azlocillin and cefoperazone in both acylated and deacylated forms.Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates.Microbial siderophore-based iron assimilation and therapeutic applications.SAR and Structural Analysis of Siderophore-Conjugated Monocarbam Inhibitors of Pseudomonas aeruginosa PBP3.What we may expect from novel antibacterial agents in the pipeline with respect to resistance and pharmacodynamic principles.Structural Insights into Inhibition of Escherichia coli Penicillin-binding Protein 1B.First-principles electronic structure study of rhizoferrin and its Fe(III) complexes.How bacterial cell division might cheat turgor pressure - a unified mechanism of septal division in Gram-positive and Gram-negative bacteria.Preparation, gram-negative antibacterial activity, and hydrolytic stability of novel siderophore-conjugated monocarbam diols.Genomics and Susceptibility Profiles of Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa from Spain.Bifunctional antimicrobial conjugates and hybrid antimicrobials.Characterization of Escherichia coli NDM isolates with decreased susceptibility to aztreonam/avibactam: role of a novel insertion in PBP3.Microspectrofluorimetry to dissect the permeation of ceftazidime in Gram-negative bacteria.Molecular architecture of the PBP2-MreC core bacterial cell wall synthesis complex.Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in Pseudomonas aeruginosa.Antibacterial and β-Lactamase Inhibitory Activity of Monocyclic β-Lactams.The Versatile Mutational Resistome of Pseudomonas aeruginosa.High-Throughput Screening of Biodiversity for Antibiotic Discovery
P2860
Q26749531-17F80DE3-5DD9-4BB9-A404-ABA115923BA5Q26859841-727D02DF-4E2A-4AB7-97D5-C45865C8F029Q27677486-BE94B2EA-704C-48AD-B242-E50F3BA55C05Q27704666-144E8F2D-18FC-4AE8-AB6A-0113C152ACC2Q28078130-C5DDB4E0-87D8-4232-B1E2-7ABB25FB81A5Q33911762-80559E8B-5BD9-4368-ACE9-61E23A585A57Q34310470-1647D5FA-A55B-414B-A4EA-FD24E66655D1Q34425933-DB1D39A3-1418-4940-BA90-3AB24604F6A4Q37428703-7D8D242C-2791-4BE0-AAD9-D03735D29B02Q37990947-25183230-D5C9-403D-815C-1781F8375C38Q38021726-C49CB730-06F8-48BB-911E-FA5499C2668FQ38076456-2D4C567D-0660-4CDD-BEC2-2005728996C1Q38162949-1BD88ADC-59BF-4E69-860E-10688728A6F5Q38600036-A6828A11-95A7-4FD3-AC27-CECEE9BF69BBQ38741337-BE1C1E75-45F0-4F0B-95A3-290B4B631CF8Q38825854-0DFD6591-C86B-4C94-A94C-571439B0C9B2Q39003082-AC1E1FE3-0EE7-4523-87B3-28F988579AE8Q39120027-D389E2BA-9135-4CBE-A071-2A749626E933Q39144682-2B95331C-B50C-4F1A-A1E1-B26EB5CF59F8Q39344981-DD549169-817D-44D7-9FD6-D7AB2B359149Q39429979-AB4FD645-5827-4348-9FD2-32524E7C3154Q39513210-07311AE9-9791-4C1D-9F91-1762B9451329Q40056971-624F31A0-D727-4592-B756-5450FFBC061DQ40203926-4BD28A4C-A500-4B3E-B93F-69F73854F757Q41514048-F9AB0F13-3B3B-442E-B731-D131E9C842CCQ41986608-7B15B27E-22A3-413D-91F5-7855C9C5EF0BQ42282697-3B8C262D-15DF-41F4-832B-F8BED91157D5Q45897898-BCD1DEFF-38F9-43DF-81F7-E3D83D6CD7FAQ47786477-4257F875-4631-4EA4-80F9-D7C733F6A57EQ52313185-840EAB3B-B3A2-41BA-AA32-0A43284E947FQ58569022-0B965E75-C471-45FF-954D-AFB84BB6BCE2
P2860
Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of Pseudomonas aeruginosa
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Structural basis for effective ...... ains of Pseudomonas aeruginosa
@ast
Structural basis for effective ...... ains of Pseudomonas aeruginosa
@en
Structural basis for effective ...... ains of Pseudomonas aeruginosa
@nl
type
label
Structural basis for effective ...... ains of Pseudomonas aeruginosa
@ast
Structural basis for effective ...... ains of Pseudomonas aeruginosa
@en
Structural basis for effective ...... ains of Pseudomonas aeruginosa
@nl
prefLabel
Structural basis for effective ...... ains of Pseudomonas aeruginosa
@ast
Structural basis for effective ...... ains of Pseudomonas aeruginosa
@en
Structural basis for effective ...... ains of Pseudomonas aeruginosa
@nl
P2093
P2860
P3181
P356
P1476
Structural basis for effective ...... ains of Pseudomonas aeruginosa
@en
P2093
Andrew P Tomaras
Artem Evdokimov
Brian M Lacey
Eric S Marr
J Richard Miller
Richard P Zaniewski
Seungil Han
Veerabahu Shanmugasundaram
P2860
P304
P3181
P356
10.1073/PNAS.1013092107
P407
P577
2010-12-21T00:00:00Z